Multidisciplinary approaches optimize contract drug discovery
Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development
Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development
Dr. Ana de Oliveira from the Spatial Biology Core at UVA discusses the potential of the field to supercharge research across sectors
The largest open-access proteogenomic dataset to date lays the groundwork for the future discovery of novel drug targets and biomarkers
Explore the latest technologies and techniques that will help you advance biopharma pipelines
Researchers in the US are using multiplex immunofluorescence to unravel the complexities of the spatial biology within the microenvironment of brain tumors
Discover the latest technologies and methods advancing small molecule therapeutic discovery and development, from PROTAC quantification to microsampling innovations
Automation of emerging technologies is fast-tracking spatial biology breakthroughs
The brand-new SelectScience T-shirts and EXCLUSIVE festive sweater are here, find out how you could win one
Advancements in antibody-based techniques present an efficient and powerful means by which to investigate post-translational modifications
Omics expert, Professor Gary Patti, shares his thoughts on the current trends in metabolomics and discusses how multiple omics datasets can enhance our understanding of biology and disease
Discover the latest technologies and methods to advance your biopharma research, from droplet digital PCR to next-gen protein sequencing and nanoparticle characterization
This special feature explores how researchers are examining the microenvironment of complex tumors, and highlights the recent advancements in microscopy and the latest discoveries driving progress in spatial biology research
Platinum®, Quantum-Si’s innovative protein sequencing platform, could bring affordable, benchtop protein sequencing with automated analysis to every lab
Olink is sponsoring a Cancer Biomarker Discovery Challenge for Innovative Researchers in Europe
Discover the game-changing advancements and key discussions driving lab automation forward
These automated solutions have been designed to offer time savings and improved throughput whilst still providing great reproducibility and robustness
Watch this on-demand webinar to discover how deep phenotyping is enabling the study of complex diseases and biomarker discovery
Watch this on-demand webinar, to explore how to determine antibody response against the SARS-CoV-2 Spike RBD
Discover educational webinars and downloads on antibody discovery, proteomics, PCR, and more
Gain insights from industry leaders specializing in the therapeutic use of targeted protein degradation